Lilly Diabetes and Disney Publishing Worldwide Expand Collaboration
Custom Publications Will be Delivered to Families Affected by Type 1 Diabetes
Throughout the World
INDIANAPOLIS, April 30, 2013
INDIANAPOLIS, April 30, 2013 /PRNewswire/ --
oLilly Diabetes expands collaboration with Disney Publishing Worldwide
oNew educational resources will be available soon for families of children
with type 1 diabetes.
Lilly Diabetes today announced the global expansion of its innovative
collaboration with Disney Publishing Worldwide (DPW), which expands the
program internationally based on the success of the initiative in the U.S.,
which began in 2011. The goal of the program is to bring thoughtful
educational resources to families of children with diabetes, including a
series of custom books co-created by Lilly Diabetes and DPW for children of
various ages and stages of life who are living with type 1 diabetes. The
books, available through diabetes healthcare professionals, will initially be
translated and available in 18 countries.
"Lilly Diabetes' objective is to bring safety, health, comfort and a bit of
magic to children worldwide," said Andrew Hodge, vice president,
International, Lilly Diabetes. "We saw the positive impact our collaboration
with Disney Publishing Worldwide had on families living with type 1 diabetes
in the U.S. over the last two years, and we are excited to expand our reach
Nearly 500,000 young people worldwide are living with type 1 diabetes, and an
estimated 78,000 are diagnosed each year. From the moment of diagnosis to
the day-in, day-out management of the disease, the challenges of living with
the disease can be overwhelming for children and their families. People with
type 1 diabetes must follow a structured self-management regimen that includes
a balance of medication, physical activity and a healthy diet.
By expanding this collaboration, Lilly Diabetes and DPW hope to reach even
more families who have been impacted by type 1 diabetes – emphasizing what
they can do instead of what they can't do, and offering stories of familiar
characters, such as Mickey Mouse and his friend Coco, the fun-loving monkey
who has type 1 diabetes.
"We are excited to be part of this effort to bring informational material
about type 1 diabetes to kids around the world who are living with the
disease," said Andrew Sugerman, executive vice president, DPW. "Lilly
Diabetes' expertise with the disease, combined with Disney's tradition of
great storytelling, gives us an opportunity to inspire and motivate children
and families with type 1 diabetes."
About Disney Publishing Worldwide
Disney Publishing Worldwide (DPW) is the world's largest publisher of
children's books and magazines with over 700 million products sold each year.
Disney Publishing Worldwide consists of an extensive worldwide licensing
structure as well as vertically integrated publishing imprints, including
Disney Book Group in the U.S., Disney Libri in Italy, and Disney Libros in
Spain. DPW publishes a range of children's magazines globally, including
Topolino, Le Journal de Mickey, and Donald Duck, as well as Disney kids
magazines in the U.S., which include Disney Princess and Phineas and Ferb.
Disney English is DPW's English language learning business, which includes
Disney English learning centers in China and a worldwide retail licensing
program. DPW's digital products include bestselling eBook titles as well as
original apps. Headquartered in Glendale, California, Disney Publishing
Worldwide publishes books, magazines, and digital products in 85 countries in
75 languages. For more information visit www.disneypublishing.com.
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced
the world's first commercial insulin. Today we work to meet the diverse needs
of people with diabetes through research and collaboration, a broad and
growing product portfolio and a continued commitment to providing real
solutions—from medicines to support programs and more—to make lives better.
For more information, visit www.lillydiabetes.com.
About Eli Lilly and Company (NYSE: LLY)
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides
answers—through medicines and information—for some of the world's most urgent
medical needs. Information about Lilly is available at www.lilly.com.
LD81967 02/2013 ©Lilly USA, LLC 2013. All rights reserved.
 "Diabetes in the Young." Adapted from: International Diabetes Federation,
IDF Diabetes Atlas. 2012. Available at:
http://www.idf.org/diabetesatlas/5e/diabetes-in-the-young. Accessed 28
(Logo: http://photos.prnewswire.com/prnh/20130430/DE02749LOGO )
(Logo: http://photos.prnewswire.com/prnh/20111111/DE03493LOGO )
(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )
Refer to: +1 (317) 627-4056 – Julie Williams, Lilly Diabetes
SOURCE Eli Lilly and Company; Disney Publishing Worldwide
Press spacebar to pause and continue. Press esc to stop.